Market Cap : 103.11 M | Enterprise Value : | PE Ratio : N/A | PB Ratio : 0.23 |
---|
NAS:AQB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:AQB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
AquaBounty Technologies's Capital Expenditure for the three months ended in Jun. 2022 was $-24.71 Mil. Its Revenue for the three months ended in Jun. 2022 was $1.07 Mil.
Hence, AquaBounty Technologies's Capex-to-Revenue for the three months ended in Jun. 2022 was 23.09.
The historical data trend for AquaBounty Technologies's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, AquaBounty Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, AquaBounty Technologies's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where AquaBounty Technologies's Capex-to-Revenue falls into.
AquaBounty Technologies's Capex-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-5.714) | / | 1.175 | |
= | 4.86 |
AquaBounty Technologies's Capex-to-Revenue for the quarter that ended in Jun. 2022 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-24.711) | / | 1.07 | |
= | 23.09 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Thank you for viewing the detailed overview of AquaBounty Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sharp Erin S | director | THE KROGER CO. 1014 VINE STREET CINCINNATI OH 45202 |
Stern Michael K | director | 800 N. LINDBERGH BLVD, A3SA ST LOUIS MO 63167 |
Myers Gail Sharps | director | 13515 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277 |
Alvarez Ricardo J | director | 2 MILL AND MAIN PLACE, SUITE 395 MAYNARD MA 01754 |
Olsen Angela M | officer: General Counsel & Corp Sec | C/O AQUABOUNTY TECHNOLOGIES, INC. 2 MILL & MAIN PLACE, SUITE 395 MAYNARD MA 01754 |
Wulf Sylvia | director, officer: CEO & Director | 2 MILL & MAIN PLACE, SUITE 395 MAYNARD MA 01754 |
Czypinski Alana | director | 1881 GROVE AVENUE RADFORD VA 24141 |
Fisher Theodore John | director | 1881 GROVE AVENUE RADFORD VA 24141 |
Perez Jeffrey Thomas | director | 20358 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 |
Abbott Laboratories | 10 percent owner | 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 |
Kirk Randal J | 10 percent owner | 1881 GROVE AVENUE RADFORD VA 24141 |
Cfr International Spa | 10 percent owner | 100 ABBOTT PARK ROAD AP6A-2, D-032L ABBOTT PARK IL 60064-6092 |
Martin Christopher H. | officer: See Remarks | 2 MILL & MAIN PLACE, SUITE 395 MAYNARD MA 01754 |
Stotish Ronald L | director, officer: See Remarks | 2 MILL & MAIN PLACE, SUITE 395 MAYNARD MA 01754 |
Rojas Alejandro | officer: See Remarks | TWO CLOCK TOWER PLACE SUITE 395 MAYNARD MA 01745 |
From GuruFocus
Other Sources
By Zacks 2020-05-05
By Zacks 2021-08-04
By Fool 2020-12-10
By Zacks 2021-11-04
By Zacks 2020-12-24
By Zacks 2022-03-10
By Zacks 2022-03-15
By Fool 2021-02-04
By Fool 2021-02-02
By Fool 2021-03-24
By Seekingalpha 2020-12-03